FDA & Government News

June 18, 2026

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

Conexiant

June 18, 2026

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Conexiant

June 15, 2026

FDA Expands OTC CGM Access to Children

The device was previously cleared for adults aged 18 years and older in March 2024.

Conexiant

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Conexiant

June 11, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

June 11, 2026

FDA Clears Home Urine Collection Kit for STI Testing

The clearance enables a validated mail-in workflow for self-collected urine specimens processed on Roche cobas systems.

Conexiant

June 10, 2026

FDA Approves Less Frequent Lebrikizumab Dosing

Approval adds an every-8-week maintenance option for eligible patients with moderate-to-severe atopic dermatitis.

Conexiant

June 10, 2026

Weekly HIV Regimen Meets Phase 3 Goal

The investigational combination pairs islatravir and lenacapavir in a once-weekly single-tablet regimen.

Conexiant

June 09, 2026

FDA Permits New Sunscreen Ingredient After 20 Years

The sunscreen ingredient, which has been marketed internationally for years, is considered generally recognized as safe and effective for use in adults and pediatric patients aged 6 months and older.

Conexiant

June 08, 2026

FDA Expands Marstacimab Indication in Hemophilia A and B

Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations.

Conexiant

Earlier Egg Intake Linked to Less Allergy

FDA & Government News

FDA Expands CAPVAXIVE Pediatric Use

Top 10 FDA Recalls Physicians Should Know

FDA Expands OTC CGM Access to Children

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

When Bad Data Enters the Drug Pipeline

Daily News

FDA Clears Home Urine Collection Kit for STI Testing

FDA Approves Less Frequent Lebrikizumab Dosing

Weekly HIV Regimen Meets Phase 3 Goal

FDA Permits New Sunscreen Ingredient After 20 Years

FDA Expands Marstacimab Indication in Hemophilia A and B

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Earlier Egg Intake Linked to Less Allergy

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

Conexiant

AACE Endocrinology AI

Conexiant

GI & Hepatology News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

FDA & Government News

Daily News

Recommendations